These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Recent results with clinically used antineoplastic drugs and drug combinations in vivo. Arnold W; Tanneberger S; Nowak C; Naundorf H Oncology; 1980; 37 Suppl 1():34-41. PubMed ID: 7454199 [TBL] [Abstract][Full Text] [Related]
4. [Antineoplastic properties of complex compounds of platinum(II)]. Presnov MA; Konovalova AL; Stetsenko AI; Ivanov VF; Iakovlev KI Dokl Akad Nauk SSSR; 1976 Oct; 230(6):1357-9. PubMed ID: 976058 [No Abstract] [Full Text] [Related]
5. Further studies on the tumor inhibitory effects of carbobenzoxy derivatives of amino acids. Shohat B; Schlesinger M; Grossowicz N; Lichtenstein N Isr J Med Sci; 1972 Jan; 8(1):29-33. PubMed ID: 5067528 [No Abstract] [Full Text] [Related]
6. Collateral sensitivity of resistant lines of mouse leukemias L1210 and L5178Y. Schmid FA; Hutchison DJ Cancer Res; 1972 Apr; 32(4):808-12. PubMed ID: 5014791 [No Abstract] [Full Text] [Related]
7. Antitumor activity of amidoximes (hydroxyurea analogs) in murine tumor systems. Flora KP; van't Riet B; Wampler GL Cancer Res; 1978 May; 38(5):1291-5. PubMed ID: 639062 [TBL] [Abstract][Full Text] [Related]
8. Cyclophosphamide-adriamycin combination chemotherapy of transplantable murine tumors. Corbett TH; Griswold DP; Mayo JG; Laster WR; Schabel FM Cancer Res; 1975 Jun; 35(6):1568-73. PubMed ID: 1131824 [TBL] [Abstract][Full Text] [Related]
9. Antitumor activity of 5-formamido-1- D-ribofuranosylthioimidazole-4-carboxamide 2',3',5'-triformate in a variety of animal tumors. Hoshi A; Kanzawa F; Kuretani K Cancer Chemother Rep; 1971 Jun; 55(3):229-31. PubMed ID: 5115844 [No Abstract] [Full Text] [Related]
10. Modification of transplantability and tumor growth following treatment of L1210 leukemia and TA3Ha cells with macromomycin (NSC-170105). Lippman MM; Abbott BJ Cancer Chemother Rep; 1973; 57(4):501-3. PubMed ID: 4762442 [No Abstract] [Full Text] [Related]
11. Screening data from the Cancer Chemotherapy National Service Center Screening Laboratories. XXI. Leiter J; Abbott BJ; Schepartz SA Can Res Suppl; 1964 Dec; ():1093-353. PubMed ID: 5878218 [No Abstract] [Full Text] [Related]
12. Exploratory studies of vitamin A and cyclophosphamide in tumor-bearing mice. Nathanson L; Maddock CL; Hall TC J Clin Pharmacol J New Drugs; 1969; 9(6):359-73. PubMed ID: 5260199 [No Abstract] [Full Text] [Related]
13. Kinetics of cancer cell kill by chemotherapeutic agents in vivo. Wilcox WS Natl Cancer Inst Monogr; 1967 Feb; 24():257-69. PubMed ID: 6021080 [No Abstract] [Full Text] [Related]
14. Screening data from the Cancer Chemotherapy National Service Center Screening Laboratories. XV. Leiter J; Abbott BJ; Bourke AR; Schepartz SA; Wodinsky I Cancer Res; 1963 Sep; 23(8 Pt 2):1483-729. PubMed ID: 5878214 [No Abstract] [Full Text] [Related]
15. [Potentiation of the antitumor action of alkylating compounds by amphotericin B]. Iaremenko KV; Eremeeva AA; Tereshin IM Antibiotiki; 1977; 22(2):153-8. PubMed ID: 404957 [No Abstract] [Full Text] [Related]
16. Kinetic evaluation of the effect of hydroxyurea on viability of replicating cultured leukemia L1210 cells. Wilkoff LJ; Lloyd HH; Dulmadge EA; Dixon GJ J Natl Cancer Inst; 1970 Jan; 44(1):201-9. PubMed ID: 11515031 [No Abstract] [Full Text] [Related]
17. Approaches to combination chemotherapy in rat, mouse, and hamster tumors. Griswold DP; Dykes DJ; Kelley CA; Roberts BJ; Dominick CA Cancer Chemother Rep 2; 1974 Mar; 4(1):99-108. PubMed ID: 4524043 [No Abstract] [Full Text] [Related]
18. A modified screening system to select new cytostatic drugs. Kraemer HP; Sedlacek HH Behring Inst Mitt; 1984 May; (74):301-28. PubMed ID: 6383326 [No Abstract] [Full Text] [Related]
19. Are syngeneic mouse tumor models still valuable experimental models in the field of anti-cancer drug discovery? Darro F; Decaestecker C; Gaussin JF; Mortier S; Van Ginckel R; Kiss R Int J Oncol; 2005 Sep; 27(3):607-16. PubMed ID: 16077908 [TBL] [Abstract][Full Text] [Related]
20. [Experiment to potentiate the effect of cyclophosphamide combined with tempidon and caffeine in leukemia L1210 and Lewis hepatic carcinoma]. Stoichkov I; Milushev A; Todorov D Eksp Med Morfol; 1978; 17(1):9-14. PubMed ID: 639751 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]